{
  "id": 3822083,
  "title": "S&P upgrades Concentra rating to BB on lower leverage",
  "url": "https://urgent.news/2026/08/27/s-p-upgrades-concentra-rating-to-bb-on-lower-leverage",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-27T21:32:42.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/sp-upgrades-concentra-rating-to-bb-on-lower-leverage-93CH-4880265"
  },
  "original_language": "en",
  "account": "S&P Global Ratings has boosted Concentra Group Holdings Parent Inc.'s credit rating to BB from BB-, recognizing the company's solid operating performance and reduced financial risk following its split from Select Medical. The agency also enhanced the senior secured term loan rating to BB+ from BB and upgraded unsecured notes to B+ from B, while maintaining recovery ratings at 2 and 6, respectively. Concentra's leverage, as measured by S&P Global Ratings, dipped below 3.5x in the second quarter, a full two quarters ahead of earlier projections. The company's adjusted leverage stands at 3.3x for fiscal 2026 and is expected to decrease to 3x in fiscal 2027. Management has set a target net leverage of 2.5x, or 3x on an S&P Global Ratings-adjusted basis, including leases. In 2025, Concentra generated roughly $250 million in annual free operating cash flow after investing about $320 million in acquisitions of Nova Medical Centers and Pivot Onsite Innovations. The company's rolling-12-month S&P Global Ratings-adjusted EBITDA has risen by over $100 million since fiscal 2024, fueled by a surge in workers' compensation visits, rate increases, staffing efficiencies, and cost controls. Concentra commands around 25% of the occupational health market, with 64% of employer locations within 12 miles of a center and a presence in 85 of the 100 largest metropolitan statistical areas. The company maintains mid-20% range EBITDA margins, with most revenue coming from employers and workers' compensation programs, with less than 1% from government payers. S&P Global Ratings has assigned a stable outlook, predicting Concentra will continue to keep leverage under the 3.5x threshold. However, potential downgrade risks include sustained leverage above 3.5x due to excessive M&A or shareholder returns, or business decline from competition, lower injury rates, economic downturns, or state rate reductions. This report was produced with AI assistance and reviewed by an editor.",
  "summary": null,
  "key_points": [
    "S&P upgrades Concentra Group Holdings rating to BB from BB-",
    "Company's leverage dipped below 3.5x in Q2, below earlier projections",
    "Management targets net leverage of 2.5x or 3x on S&P Global-adjusted basis"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}